BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27834297)

  • 1. Identification of Rate-Limiting Steps in the Provision of Thrombolytics for Acute Ischemic Stroke.
    Metts EL; Bailey AM; Weant KA; Justice SB
    J Pharm Pract; 2017 Dec; 30(6):606-611. PubMed ID: 27834297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.
    Kamal N; Holodinsky JK; Stephenson C; Kashayp D; Demchuk AM; Hill MD; Vilneff RL; Bugbee E; Zerna C; Newcommon N; Lang E; Knox D; Smith EE
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Delays for Patients With Acute Ischemic Stroke in an Iranian Emergency Department: A Retrospective Chart Review.
    Hassankhani H; Soheili A; Vahdati SS; Mozaffari FA; Fraser JF; Gilani N
    Ann Emerg Med; 2019 Feb; 73(2):118-129. PubMed ID: 30318375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
    Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prehospital and Emergency Department-Focused Mission Protocol Improves Thrombolysis Metrics for Suspected Acute Stroke Patients.
    Madhok DY; Keenan KJ; Cole SB; Martin C; Hemphill JC
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104423. PubMed ID: 31606319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
    Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
    Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist Participation in Acute Ischemic Stroke Decreases Door-to-Needle Time to Recombinant Tissue Plasminogen Activator.
    Rech MA; Bennett S; Donahey E
    Ann Pharmacother; 2017 Dec; 51(12):1084-1089. PubMed ID: 28759998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving door-to-needle times: a single center validation of the target stroke hypothesis.
    Ruff IM; Ali SF; Goldstein JN; Lev M; Copen WA; McIntyre J; Rost NS; Schwamm LH
    Stroke; 2014 Feb; 45(2):504-8. PubMed ID: 24399372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.
    Itabashi R; Shigehatake Y; Yazawa Y; Endo K; Saito T; Fukuma K; Furui E; Mori E
    J Neurol Sci; 2019 Aug; 403():59-64. PubMed ID: 31226551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol.
    Tan BYQ; Ngiam NJH; Sunny S; Kong WY; Tam H; Sim TB; Leong BSH; Bhartendu C; Paliwal PR; Seet RCS; Chan BPL; Teoh HL; Sharma VK; Yeo LLL
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1539-1545. PubMed ID: 29422380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative Interventions Reduce Time-to-Thrombolysis for Acute Ischemic Stroke in a Public Safety Net Hospital.
    Threlkeld ZD; Kozak B; McCoy D; Cole S; Martin C; Singh V
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1500-1505. PubMed ID: 28396187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
    Gosser RA; Arndt RF; Schaafsma K; Dang CH
    J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative.
    Fonarow GC; Smith EE; Saver JL; Reeves MJ; Hernandez AF; Peterson ED; Sacco RL; Schwamm LH
    Stroke; 2011 Oct; 42(10):2983-9. PubMed ID: 21885841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Telestroke Treatment Times in an Expanding Network of Hospitals.
    Sanders KA; Patel R; Kiely JM; Gwynn MW; Johnston LH
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):288-91. PubMed ID: 26654667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.